BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health.
7th June 2019, Paris, France –BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health.
Inserm made the strategic decision to digitize its laboratory workflows in a uniform way by making Labguru available to all 15,000 of its staff based within its 14 thematic institutes. This follows a successful three year long pilot which saw 300 participants using the product across different research sites.
Inserm piloted the project across a diverse range of its research areas including neurosciences, cancer, inflammation and cell biology. This allowed them to test and collate the widest possible range of data in Labguru’s secure digital space which can then be accessed and reviewed in real time.
Claudia Gallina and Paul-Guy Dupre, ELN implementation Project Managers, said: “With Labguru, Inserm now offers its 1,300 research teams, distributed throughout France, a powerful Electronic Lab Notebook and Inventory Management system solution. The major change for Inserm researchers, compared to the paper version, is the ability to remotely access data, carry out collaborative work and simplify research traceability by providing excellent data search functions.
“For managers, the ELN enables better team and project management. It also facilitates the preservation and transmission of knowledge and the security of the research data which is now centralized and backed up. Inserm’s researchers are able to better organize the management of knowledge and quality procedures.”
Steve Yemm, CEO of BioData the company behind Labguru said: “I am delighted that our flagship product has enabled Inserm to bring productivity improvements and a high standard of quality to the work their teams are doing. When working on a specific scientific procedure, Inserm is now able to quickly and effectively document experiments, manage inventory items and track the steps taken in the scientific workflow. Labguru has also replaced the need for printing and manual exchange of data and reports saving time and money.”
Records of the equipment and samples used in experiments can now be easily maintained as soon as the work is completed and documented in Labguru. Lead investigators are able to trace all of the work carried out by post-doctorates, PhD candidates and other staff through the ELN system meaning everything is uniformly recorded.
Labguru has also made a contribution to improving experimental success rates. Researchers are now able to trace the root causes of experiment failure, helping to improve outcomes in the future. It keeps the traceability and quality in check so users have a full picture not just of the experiment itself but also the inventory that was used.
Inserm joins other major pharmaceutical organizations, biotechnology companies, research hospitals, individual academic labs, and independent research institutions which have successfully deployed Labguru’s Electronic Lab Notebook.
To learn more about Labguru, visit www.labguru.com, or call us at +1-617-714-9952.
ENDS
For further press information please contact: Tom Mellor, The Scott Partnership: + 44 1477 539539 mail to biodata@scottpr.com.
About BioData
BioData delivers SaaS software solutions for institutions and companies in the life sciences. BioData´s flagship product Labguru is a secure, web-based Electronic Lab Notebook (ELN) which records and manages laboratory data and inventory, helping labs to run more efficiently. With Labguru, scientists can design experiments and workflows, capture structured and unstructured data, manage projects, and share their work. Customisable experiment templates, integration of protocols, SOPs, and other cutting-edge features help to increase data quality, streamline workflows and reduce costs. BioData is part of the Digital Science portfolio of companies all working together to help researchers make a difference. For more information, visit www.labguru.com.
About Inserm
Inserm is France’s only public research institute to focus entirely on human health. Established in 1964, Inserm is a public institution of scientific and technological nature, under the dual supervision of the Ministry of Health and the Ministry of Research. The organization has a research output of over 93,000 peer-reviewed articles and over 3,000 patents since 1977. For more information visit www.inserm.fr.
